President Donald Trump sent letters to 17 of the world’s largest pharmaceutical companies — including Eli Lilly & Co., Novo ...

President Trump escalated efforts to reduce drug prices in the US on Thursday, releasing letters sent to 17 pharmaceutical ...

EU court’s finding against executive’s handling of text message exchange between Ursula von der Leyen and Pfizer CEO will ...

Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure, he said ...

Plus: All the news and watercooler chat from Fortune. Good morning. Pfizer’s Albert Bourla has become a fixture among Fortune 500 CEOs, having run the pharma giant since 2018.

Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the pharmaceutical giant's struggling share price and refine its strategic ...

Read was Pfizer's (PFE) chief executive officer from 2010 to 2018 and picked Pfizer's current CEO Albert Bourla as his successor. D’Amelio was Pfizer's chief financial officer from 2007 to 2021.

It's not clear yet if one is needed. Bourla said Pfizer is also hoping to make a vaccine that will protect against Omicron and all other variants of SARS-CoV-2 -- the virus that causes Covid-19.

Pfizer Inc. (NYSE: PFE) Goldman Sachs 45th Annual Global Healthcare Conference June 10, 2024 11:20 AM ET Company Participants Albert Bourla - Chairman and CEO Conference Call Participants Chris ...

Pfizer reaffirmed $10–$15 billion for business development, with focus on immunology and cardiometabolic expansion. CEO Bourla says national security concerns are central to U.S. drug ...

Activist investor Starboard Value claims the pharma giant's former CEO and CFO were 'threatened' into backing current CEO Albert Bourla Pfizer Inc.'s stock dipped 2.5% Thursday as the company's ...